ArticleJSES international2025
Non-cefazolin antibiotic prophylaxis is associated with increased rates of acute infectious, medical, and surgical complications following primary total shoulder arthroplasty: a database study.
Article in JSES international, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hypothesis: This study aimed to evaluate different prophylactic antibiotic regimens and risk for acute postoperative readmissions, infections, and medical complications. Methods: This retrospective cohort study used the Premier Healthcare Database to identify patients who underwent primary elective shoulder arthroplasty procedures over the age of 18. The database was queried to identify perioperative antibiotic regimens using specific codes for cefazolin, clindamycin, and vancomycin. Patients receiving cefazolin monotherapy for prophylactic antibiotic regimen were used as a control group and multivariate logistic regression was then used to calculate odd ratios for postoperative complications within 90 days of the procedure. Results: A total of 139,032 patients undergoing primary shoulder arthroplasty between 2016 and 2020 were included. Cefazolin monotherapy was the most prescribed antibiotic regimen (59.3%), followed by vancomycin and cefazolin combination therapy (23.3%), vancomycin monotherapy (8.6%), clindamycin monotherapy (5.6%), and vancomycin and clindamycin combination therapy (3.2%). Monotherapy with clindamycin or vancomycin was associated with increased risk of periprosthetic joint infection ( Conclusion: Compared to vancomycin and clindamycin monotherapy, cefazolin monotherapy was associated with a lower risk of developing acute postoperative periprosthetic joint infection. The results of this study support the use of cefazolin monotherapy as the current standard for patients undergoing primary total shoulder arthroplasty.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.